Niagen Bioscience, Inc. Common Stock

NAGENASDAQUSD
4.77 USD
0.02 (0.42%)🟢PRE MARKET (AS OF 04:02 AM EDT)
🟢Market: OPEN
Open?$4.82
High?$4.82
Low?$4.78
Prev. Close?$4.76
Volume?163
Avg. Volume?782.5K
VWAP?$4.82
Rel. Volume?0.00x
Bid / Ask
Bid?$4.76 × 100
Ask?$4.79 × 100
Spread?$0.03
Midpoint?$4.78
Valuation & Ratios
Market Cap?387.6M
Shares Out?80.1M
Float?48.4M
Float %?60.5%
P/E Ratio?22.30
P/B Ratio?5.06
EPS?$0.22
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?4.86Strong
Quick Ratio?3.83Strong
Cash Ratio?3.25Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
78/100
P/E?
22.3FAIR
P/B?
5.06FAIR
P/S?
2.99CHEAP
P/FCF?
29.3FAIR
EV/EBITDA?
18.9FAIR
EV/Sales?
2.49CHEAP
Returns & Efficiency
ROE?
22.7%STRONG
ROA?
16.3%STRONG
Cash Flow & Enterprise
FCF?$13.2M
Enterprise Value?$322.8M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Employees
117
Market Cap
387.6M
Industry
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Listed
2008-06-24
Address
10900 WILSHIRE BLVD
LOS ANGELES, CA 90024
Phone: 310-388-6706